This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Endocrinology, Subject name: Medicine
[{'content': 'Which of the following is an SGLT 2 inhibitor approved for treatment of type 2 diabetes Mellitus \nSelect and explain. \nA. Dulaglutide, B. Pramilintide, C. Canagliflozin, D. Nateglinide', 'role': 'user'}, {'content': 'Answer: C \nExplanation: Canagliflozin, empagliflozin, dapagliflozin, remogliflozin are sglt 2 inhibitors approved for treatment of type 2 diabetes Ref Harrison 20th edi page no 2866, table 397-5', 'role': 'assistant'}]